IRIS - Res&Arch Institutional Research Information System - Research & Archive

Ingrosso, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.946
AS - Asia 1.697
EU - Europa 1.246
SA - Sud America 331
AF - Africa 30
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.891
SG - Singapore 877
IE - Irlanda 354
HK - Hong Kong 319
BR - Brasile 288
IT - Italia 273
CN - Cina 242
RU - Federazione Russa 214
DE - Germania 95
VN - Vietnam 92
FR - Francia 51
GB - Regno Unito 49
KR - Corea 48
FI - Finlandia 35
CA - Canada 30
PL - Polonia 29
AT - Austria 23
UA - Ucraina 23
AR - Argentina 21
NL - Olanda 21
JP - Giappone 20
SE - Svezia 18
BD - Bangladesh 17
MX - Messico 17
IN - India 16
CH - Svizzera 14
TR - Turchia 11
CZ - Repubblica Ceca 8
ES - Italia 8
UZ - Uzbekistan 8
ZA - Sudafrica 8
IQ - Iraq 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
IL - Israele 6
LT - Lituania 6
MA - Marocco 5
EC - Ecuador 4
GR - Grecia 4
AU - Australia 3
BG - Bulgaria 3
DZ - Algeria 3
IR - Iran 3
LB - Libano 3
NP - Nepal 3
PK - Pakistan 3
PS - Palestinian Territory 3
VE - Venezuela 3
CO - Colombia 2
CR - Costa Rica 2
EG - Egitto 2
ID - Indonesia 2
JM - Giamaica 2
JO - Giordania 2
LV - Lettonia 2
NG - Nigeria 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.255
Salva come PNG Salva come JPEG
Città #
Singapore 568
Dublin 352
Hong Kong 319
Chandler 255
Boardman 158
Altamura 120
San Mateo 119
Santa Clara 114
Ashburn 97
Lawrence 73
Medford 73
Princeton 73
Seoul 47
Beijing 45
Munich 42
Moscow 41
Los Angeles 39
Andover 33
The Dalles 31
São Paulo 29
Wilmington 28
Perugia 27
New York 26
Ho Chi Minh City 24
Houston 24
Hanoi 20
Warsaw 20
Ann Arbor 19
Des Moines 18
Piscataway 18
Tokyo 18
Saint Petersburg 17
Turku 17
Nuremberg 16
Redmond 16
Frankfurt am Main 15
Brooklyn 14
Dallas 14
Norwalk 14
Atlanta 13
Milan 12
Boston 11
Dong Ket 11
Helsinki 11
Montreal 11
Falls Church 10
Phoenix 10
Stockholm 10
Toronto 10
Amsterdam 9
Paris 9
Poplar 9
Rome 9
San Paolo di Civitate 9
Chicago 8
Johannesburg 8
Menlo Park 8
Orem 8
Redwood City 8
San Francisco 8
Vienna 8
Brasília 7
Chennai 7
Guangzhou 7
Hefei 7
Ankara 6
Belo Horizonte 6
Columbus 6
Denver 6
Lausanne 6
Mexico City 6
Prato 6
Terni 6
Bologna 5
Brussels 5
Curitiba 5
Goiânia 5
Haiphong 5
Lappeenranta 5
Lima 5
London 5
Porto Alegre 5
Rio de Janeiro 5
Shanghai 5
Bauru 4
Bexley 4
Biên Hòa 4
Changsha 4
Fairfield 4
Falkenstein 4
Florence 4
Francavilla al Mare 4
Nova Iguaçu 4
Salvador 4
Seattle 4
Anoia 3
Buenos Aires 3
Frankfurt Am Main 3
Jacksonville 3
Kiryat Ono 3
Totale 3.393
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 139
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 108
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 88
Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients 84
Helical tomotherapy re-irradiation for patients affected by local radiorecurrent prostate cancer 83
Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: A volumetric off-line analysis in relation to the variations of rectal and bladder volumes 81
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 81
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence 79
Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer 79
Acute and late toxicity after three-dimensional conformal image-guided radiotherapy for localized prostate cancer 78
Stereotactic radiotherapy for brain metastases: Imaging tools and dosimetric predictive factors for radionecrosis 77
Breakdown of symbiosis in radiation-induced oral mucositis 77
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 76
Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience 76
Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer 76
Physician And Patient Barriers To Radiotherapy Service Access: Treatment Referral Implications 74
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 73
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 73
Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial 71
Current therapeutic options in metastatic castration-resistant prostate cancer 70
Prostate Cancer Recurrence in Kidney Transplant Recipient 15 Years After Radical Prostatectomy: A Case Report. 70
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 69
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 68
Effect of internal port on dose distribution in post-mastectomy radiotherapy for breast cancer patients after expander breast reconstruction 65
Guidelines on prostate carcinoma - AIRO, 2016 65
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 65
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 64
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 64
Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature. 64
Stereotactic radiotherapy for brain oligometastases 64
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 62
Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis 62
Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy 61
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 61
Stereotactic radiotherapy for liver oligometastases 61
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective 60
Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases 59
Pulmonary function in stereotactic body radiotherapy with helical tomotherapy for primary and metastatic lung lesions 59
Evaluation of serrated intraprostatic gold coils positional stability using on-board cone beam computed tomography scans acquired throughout the radiation treatment course 58
Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: A single cohort pilot study 58
High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool? 58
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 58
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 56
Dosimetric effect of Elekta Beam Modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer 56
Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases 56
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 56
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 56
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 53
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 52
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study 51
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 51
Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients 51
Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis 51
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 51
Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer 50
Choline PET/CT in recurrent prostate cancer 49
Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: Three longitudinal case studies 49
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review 49
Intra-parotid facial nerve schwannoma with intra-temporal extension; A case report. Is there a role for stereotactic radiotherapy? 48
Stereotactic radiotherapy for bone oligometastases 48
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 47
The time factor in oncology: Consequences on tumour volume and therapeutic planning 47
Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer 47
Stereotactic radiotherapy for lung oligometastases 47
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 46
Re: PSMA-Guided Metastases Directed Therapy for Bone Castration Sensitive Oligometastatic Prostate Cancer: A Multi-Institutional Study 46
The role of adjuvant radiother apy in the treatment of papillary tumors of the pineal region: Some general considerations and a case report 46
Volumetric image-guided conformal radiotherapy for localized prostate cancer: Analysis of dosimetric and clinical factors affecting acute and late toxicity 46
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 45
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 44
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope? 44
Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience 44
Intensity-modulated and 3D-conformal radiotherapy in hypofractionated prostate cancer treatment using Elekta Beam Modulator (TM) micro-MLC: A dosimetric analysis 44
Oligometastatic prostate cancer: The game is afoot 44
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 44
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus 43
Volumetric image-guided highly conformal radiotherapy of the prostate bed: Toxicity analysis 43
Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities 43
High-dose-rate brachytherapy with surface applicator in penile cancer 43
Oligometastatic cancer in elderly patients: the “blitzkrieg” radiotherapy approach: SBRT in oligometastatic elderly patients 42
Predicting genitourinary toxicity in three-dimensional conformal radiotherapy for localized prostate cancer: A dose-volume parameters analysis of the bladder 42
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 42
Retro-orbital granulocytic sarcoma: Case report 41
Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis 41
Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives 41
Image-guided-radiotherapy retreatment of spine metastasis: A case report and radiobiological evaluation 40
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 37
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 37
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 37
The impact of ionizing irradiation on liver detoxifying enzymes. A re-investigation 37
Stereotactic radiotherapy for oligometastases in the lymph nodes 34
Radiotherapy in the era of COVID-19 33
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 33
Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature 30
The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer 29
Editorial: Reviews in genitourinary oncology 29
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 25
Acute and late toxicities after moderate hypo-fractionated radiation therapy to the chest wall/breast and regional lymph nodes: a retrospective observational study 10
Totale 5.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 3 18 2 2 1 1 11
2021/2022464 1 52 0 6 4 5 2 152 11 33 48 150
2022/20231.118 77 264 14 50 64 97 10 60 432 3 40 7
2023/2024519 25 48 24 15 6 0 141 6 34 14 97 109
2024/20251.490 23 120 45 40 229 62 45 106 380 94 244 102
2025/20261.543 224 220 170 326 428 175 0 0 0 0 0 0
Totale 5.464